论文部分内容阅读
链褐霉素系一口服抗肿瘤抗菌素,是上海医药工业研究院于1972年在我国广东省土壤中分离到的柔毛链霉素2583的代谢产物,与国外报导的链霉黑素(Streptonigrin)基本一致。经动物实验肿瘤治疗,对不同瘤株有较明显的抑制率。经上海医工院、苏州第二制药厂及各地临床医院协作,完成了微生物、化学、药理、毒理、工艺、扩试、质量规格、临床等方面的工作,链褐霉素鉴定会于1976年12月1日至3日在苏州举行,出席会议的有来自福建、浙江、河北、四川、上海、江苏等地的代表近50名。
Streptomycin is an oral anti-tumor antibiotic, which is the metabolite of pilocarpine 2583 isolated from the soils of Guangdong Province in 1972 by the Shanghai Institute of Pharmaceutical Industry. Compared with foreign reports of Streptonigrin, Basically the same. After animal experimental tumor treatment, different tumor strains have a more obvious inhibition rate. The Shanghai Fudan University, the second pharmaceutical factory in Suzhou and clinical hospitals around the collaboration, completed the microbiology, chemistry, pharmacology, toxicology, technology, expansion, quality specifications, clinical work, etc., the identification of streptomycin in 1976 It was held in Suzhou from December 1 to December 3, with nearly 50 delegates from Fujian, Zhejiang, Hebei, Sichuan, Shanghai and Jiangsu.